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essons From a Population
he Limitations of Left Ventricular
jection Fraction as the Major
eterminant for Primary Prevention
mplantable Cardioverter-Defibrillators*
illiam J. Groh, MD, MPH, FACC
ndianapolis, Indiana
n both ischemic and nonischemic heart disease the severity
f left ventricular dysfunction has emerged as the key
eterminant affecting the decision of which patient should
eceive an implantable cardioverter-defibrillator (ICD) for
rophylaxis against a future risk of arrhythmic sudden death
1,2). A documented ejection fraction of 35% in an
therwise suitably treated patient will commonly result in an
lectrophysiology referral and an ICD implant. Although
uch treatment has yielded mortality benefit in the qualify-
ng patient, whether it can significantly impact on overall
udden death in the general population is less clear. In the
urrent issue of the Journal, Stecker et al. (3) provide
opulation-based data that unfortunately show that only a
mall proportion of sudden death victims could have bene-
ted from the current primary prevention ICD guidelines.
See page 1161
hey report results from the Oregon Sudden Unexpected
eath Study, a rigorous collection of all sudden death cases
n Multnomah County, Oregon (4). Of 714 sudden deaths
ccurring over a two-year period, only 121 patients had a
revious assessment of left ventricular function and only 36
f these patients (5% of the total) had an ejection fraction
f 35%.
It is not clear if the authors were (or could be) as rigorous
n collecting all of the patients’ medical records as they were
n ascertaining all of the sudden death cases in their
ommunity. It seems probable that some of these patients
ould have had an assessment of left ventricular function
ither not known or unavailable to the investigators. What
lso is not clear is whether the 121 patients with assessment
f left ventricular function are representative of the other
93 patients. We are informed only that other than a
oderately older age in those with left ventricular functional
ssessment, demographic and socioeconomic data are sim-
lar between the two groups. One would expect that patients
aving an indication that prompted a structural cardiac
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.t
From the Department of Medicine, Krannert Institute of Cardiology, Indiana
niversity, Indianapolis, Indiana.ssessment would be more likely to have significant left
entricular dysfunction than those without such an indica-
ion. Thus, the unevaluated group would seemingly have
ven a lesser proportion meeting primary prevention ICD
riteria.
The concept that only a minority of sudden deaths occur
n patients previously identified as having significant left
entricular dysfunction has been previously well docu-
ented in a number of studies (5–8). The Oregon investi-
ators should be commended for confirming the finding in
large general population.
Where does the current Oregon data, taken in context
ith the earlier studies, leave us regarding our ongoing
fforts to combat sudden cardiac death in our communities?
irst, because as cardiologists we treat individual patients
nd not populations, we need to continue to apply the
urrent ICD guidelines that have been shown to improve
ortality in well-designed clinical trials. Although primary
revention ICD candidates are clearly a minority of those
ubsequently suffering an out-of-hospital arrhythmia that
ould have likely been fatal if not for the ICD, it remains a
inority we can identify and help. We should learn more
bout the benefits and risks of the use of prophylactic ICDs
utside the highly controlled realm of the clinical trial with
he implementation of the ICD Registry, a combined effort
f the American College of Cardiology, the Heart Rhythm
ociety, and the Centers for Medicare and Medicaid Ser-
ices to collect nationwide data. Such data may help to
urther refine ICD guidelines over the next decade.
None of the cardiac arrest victims in the Oregon study
ad ICDs, and, by study design, patients needed to have the
ltimate adverse outcome of death to be included in the
egistry. We do not know the number of patients in
ultnomah County, Oregon, who had received an ICD
nd were prevented from having sudden death by its
resence. Such a population-based analysis would provide
omforting parallel data to the harsh realities of reporting
udden death.
Although we cannot help these Oregon sudden death
ictims, there are population-based approaches that can be
pplied to prevent sudden death. The majority of sudden
eath continues to occur in the setting of acute or chronic
schemic heart disease (9). The progress made in the U.S.
ver the last half-century in decreasing non-sudden coro-
ary deaths appears to have also resulted in a similar
ecrease in sudden deaths (10). Early identification of
oronary risk factors and primary and secondary prevention
easures should continue to decrease the population vul-
erable to sudden death. As well, communities need to
ptimize their emergency response to the cardiac arrest
ictim, thereby increasing the likelihood of survivability of
he arrhythmias associated with sudden death (11,12).
We will remain far less than perfect at predicting at what
ime and for which patient the unfortunate substrates and
riggers cross to result in sudden death. Despite this
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Editorial Comment March 21, 2006:1167–8hortcoming, the considerable progress we have made in
reventing sudden death should not be disregarded.
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